Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 1
2019 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

3 results
Results by year
Filters applied: . Clear all
Page 1
Showing results for martin hallfeldt
Your search for Martin Thalfeldt retrieved no results
A pitfall of bilateral inferior petrosal sinus sampling in cyclic Cushing's syndrome.
Albani A, Berr CM, Beuschlein F, Treitl M, Hallfeldt K, Honegger J, Schnauder G, Reincke M. Albani A, et al. BMC Endocr Disord. 2019 Oct 22;19(1):105. doi: 10.1186/s12902-019-0433-9. BMC Endocr Disord. 2019. PMID: 31640675 Free PMC article.
BACKGROUND: Clinical care of patients with cyclic Cushing's syndrome (CS) is challenging. Classical pitfalls include incorrect subtyping, unnecessary surgical procedures and delayed definite treatment. ...
BACKGROUND: Clinical care of patients with cyclic Cushing's syndrome (CS) is challenging. Classical pitfalls include incorrect subtyp …
A critical reappraisal of bilateral adrenalectomy for ACTH-dependent Cushing's syndrome.
Reincke M, Ritzel K, Oßwald A, Berr C, Stalla G, Hallfeldt K, Reisch N, Schopohl J, Beuschlein F. Reincke M, et al. Eur J Endocrinol. 2015 Oct;173(4):M23-32. doi: 10.1530/EJE-15-0265. Epub 2015 May 20. Eur J Endocrinol. 2015. PMID: 25994948 Review.
RESULTS: BADx is considered if ACTH-dependent Cushing's syndrome is refractory to other treatment modalities. In Cushing's disease (CD), BADx is mainly used as an ultima ratio after transsphenoidal surgery and medical therapies have failed. ...Specific long-term com …
RESULTS: BADx is considered if ACTH-dependent Cushing's syndrome is refractory to other treatment modalities. In Cushing's dis …
Favorable long-term outcomes of bilateral adrenalectomy in Cushing's disease.
Oßwald A, Plomer E, Dimopoulou C, Milian M, Blaser R, Ritzel K, Mickisch A, Knerr F, Stanojevic M, Hallfeldt K, Schopohl J, Kuhn KA, Stalla G, Beuschlein F, Reincke M. Oßwald A, et al. Eur J Endocrinol. 2014 Aug;171(2):209-15. doi: 10.1530/EJE-14-0214. Eur J Endocrinol. 2014. PMID: 24975318
All patients were found to be in remission after BADX. Almost all Cushing's-specific comorbidities except for psychiatric diseases improved significantly. ...The majority of patients experience considerable improvement of Cushing's symptoms....
All patients were found to be in remission after BADX. Almost all Cushing's-specific comorbidities except for psychiatric diseases im …